Skip to content

Clinical trials

Phase 3 Hemophilia B trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia B Phase: Phase 3 Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20053
20071
20081
20094
20102
20115
20124
20132
20144
20171
20184
20191
20202
20211
20224
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting7
Terminated2
Not yet recruiting1
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring8
Pfizer8
Novo Nordisk A/S6
Baxalta now part of Shire5
Bio Products Laboratory5
Wyeth is now a wholly owned subsidiary of Pfizer4
Bioverativ Therapeutics Inc.3
Genzyme, a Sanofi Company2
Medexus Pharma, Inc.2
Octapharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia B52
Hemophilia A16
Hematologic Diseases4
Hemorrhage4
Blood Coagulation Disorders3
Blood Coagulation Disorders, Inherited3
Coagulation Protein Disorders3
Genetic Diseases, Inborn3
Genetic Diseases, X-Linked3
Hemorrhagic Disorders3

Trials

Showing 76 to 52 of 52. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.